These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9411224)

  • 1. Antiphospholipid antibodies, annexin V, and pregnancy loss.
    Rote NS
    N Engl J Med; 1997 Nov; 337(22):1630; author reply 1631. PubMed ID: 9411224
    [No Abstract]   [Full Text] [Related]  

  • 2. Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.
    Rand JH; Wu XX; Andree HA; Lockwood CJ; Guller S; Scher J; Harpel PC
    N Engl J Med; 1997 Jul; 337(3):154-60. PubMed ID: 9219701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibodies, annexin V, and pregnancy loss.
    Cheng HM
    N Engl J Med; 1997 Nov; 337(22):1630-1. PubMed ID: 9411225
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies against annexin A5: detection pitfalls and clinical associations.
    Bozic B; Irman S; Gaspersic N; Kveder T; Rozman B
    Autoimmunity; 2005 Sep; 38(6):425-30. PubMed ID: 16278147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi.
    Rand JH; Wu XX; Guller S; Scher J; Andree HA; Lockwood CJ
    Am J Obstet Gynecol; 1997 Oct; 177(4):918-23. PubMed ID: 9369845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated interference with annexins in the antiphospholipid syndrome.
    Rand JH; Wu XX
    Thromb Res; 2004; 114(5-6):383-9. PubMed ID: 15507268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nîmes Obstetricians and Haematologists Study--NOHA.
    Gris JC; Quéré I; Sanmarco M; Boutiere B; Mercier E; Amiral J; Hubert AM; Ripart-Neveu S; Hoffet M; Tailland ML; Rousseau O; Monpeyroux F; Dauzat M; Sampol J; Daures JP; Berlan J; Marès P
    Thromb Haemost; 2000 Aug; 84(2):228-36. PubMed ID: 10959694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low prevalence of anti-annexin V antibodies in antiphospholipid syndrome with fetal loss].
    Siaka C; Lambert M; Caron C; Amiral J; Hachulla E; Hatron PY; Goudemand J
    Rev Med Interne; 1999 Sep; 20(9):762-5. PubMed ID: 10522297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome.
    La Rosa L; Meroni PL; Tincani A; Balestrieri G; Faden D; Lojacono A; Morassi L; Brocchi E; Del Papa N; Gharavi A
    J Rheumatol; 1994 Sep; 21(9):1684-93. PubMed ID: 7799350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of atomic force microscopy to study the pathologic effects of anti-annexin autoantibodies.
    Irman S; Skarabot M; Muševič I; Rozman B; Božič B
    J Autoimmun; 2011 Mar; 36(2):98-105. PubMed ID: 21185149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-annexin A5 antibodies in women with spontaneous pregnancy loss.
    Alijotas-Reig J; Ferrer-Oliveras R; Rodrigo-Anoro MJ; Farran-Codina I; Llurba-Olivé E; Vilardell-Tarres M; Casellas-Caro M
    Med Clin (Barc); 2010 Apr; 134(10):433-8. PubMed ID: 20022614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion.
    Rand JH; Wu XX; Guller S; Gil J; Guha A; Scher J; Lockwood CJ
    Am J Obstet Gynecol; 1994 Dec; 171(6):1566-72. PubMed ID: 7802069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression.
    Wu XX; Guller S; Rand JH
    Am J Obstet Gynecol; 2011 Dec; 205(6):576.e7-14. PubMed ID: 21871597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dr. Petri, et al reply.
    Petri M; Norman GL; Binder W; Shums Z; Akhter E; Fang H
    J Rheumatol; 2013 Sep; 40(9):1621. PubMed ID: 24137771
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antiphospholipid antibodies and recurrent abortions: possible pathogenetic role of annexin A5 investigated by confocal microscopy].
    Peluso G; Morrone G
    Minerva Ginecol; 2007 Jun; 59(3):223-9. PubMed ID: 17576401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome.
    Rand JH
    J Autoimmun; 2000 Sep; 15(2):107-11. PubMed ID: 10968894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated anti-annexin V antibody levels in antiphospholipid syndrome and their involvement in antiphospholipid antibody specificities.
    Ogawa H; Zhao D; Dlott JS; Cameron GS; Yamazaki M; Hata T; Triplett DA
    Am J Clin Pathol; 2000 Oct; 114(4):619-28. PubMed ID: 11026109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive screening analysis of antiphospholipid antibodies in Indian women with fetal loss.
    Vora S; Shetty S; Salvi V; Satoskar P; Ghosh K
    Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):136-40. PubMed ID: 17644242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis.
    Rand JH; Wu XX; Quinn AS; Taatjes DJ
    Lupus; 2010 Apr; 19(4):460-9. PubMed ID: 20353989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid syndrome in pregnancy--animal models and clinical implications.
    Shoenfeld Y; Sherer Y; Blank M
    Scand J Rheumatol Suppl; 1998; 107():33-6. PubMed ID: 9759129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.